IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-023-44512-4.html
   My bibliography  Save this article

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

Author

Listed:
  • Pooja Middha

    (University of California San Francisco)

  • Rohit Thummalapalli

    (Memorial Sloan Kettering Cancer Center)

  • Michael J. Betti

    (Vanderbilt University Medical Center)

  • Lydia Yao

    (Vanderbilt University Medical Center)

  • Zoe Quandt

    (University of California San Francisco
    University of California San Francisco)

  • Karmugi Balaratnam

    (Princess Margaret Cancer Centre)

  • Cosmin A. Bejan

    (Vanderbilt University Medical Center)

  • Eduardo Cardenas

    (University of California San Francisco)

  • Christina J. Falcon

    (Fiona and Stanley Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center)

  • David M. Faleck

    (Memorial Sloan Kettering Cancer Center)

  • Matthew A. Gubens

    (University of California San Francisco
    University of California San Francisco)

  • Scott Huntsman

    (University of California San Francisco)

  • Douglas B. Johnson

    (Vanderbilt University Medical Center)

  • Linda Kachuri

    (Stanford University School of Medicine
    Stanford University of Medicine)

  • Khaleeq Khan

    (Princess Margaret Cancer Centre)

  • Min Li

    (University of California San Francisco)

  • Christine M. Lovly

    (Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center)

  • Megan H. Murray

    (Vanderbilt University Medical Center)

  • Devalben Patel

    (Princess Margaret Cancer Centre)

  • Kristin Werking

    (Vanderbilt University Medical Center)

  • Yaomin Xu

    (Vanderbilt University Medical Center)

  • Luna Jia Zhan

    (Princess Margaret Cancer Centre)

  • Justin M. Balko

    (Vanderbilt University Medical Center)

  • Geoffrey Liu

    (Princess Margaret Cancer Centre
    Temerty School of Medicine
    University of Toronto)

  • Melinda C. Aldrich

    (Vanderbilt University Medical Center)

  • Adam J. Schoenfeld

    (Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center)

  • Elad Ziv

    (University of California San Francisco
    University of California San Francisco
    University of California San Francisco
    University of California San Francisco)

Abstract

Immune checkpoint inhibitor-mediated colitis (IMC) is a common adverse event of treatment with immune checkpoint inhibitors (ICI). We hypothesize that genetic susceptibility to Crohn’s disease (CD) and ulcerative colitis (UC) predisposes to IMC. In this study, we first develop a polygenic risk scores for CD (PRSCD) and UC (PRSUC) in cancer-free individuals and then test these PRSs on IMC in a cohort of 1316 patients with ICI-treated non-small cell lung cancer and perform a replication in 873 ICI-treated pan-cancer patients. In a meta-analysis, the PRSUC predicts all-grade IMC (ORmeta=1.35 per standard deviation [SD], 95% CI = 1.12–1.64, P = 2×10−03) and severe IMC (ORmeta=1.49 per SD, 95% CI = 1.18–1.88, P = 9×10−04). PRSCD is not associated with IMC. Furthermore, PRSUC predicts severe IMC among patients treated with combination ICIs (ORmeta=2.20 per SD, 95% CI = 1.07–4.53, P = 0.03). Overall, PRSUC can identify patients receiving ICI at risk of developing IMC and may be useful to monitor patients and improve patient outcomes.

Suggested Citation

  • Pooja Middha & Rohit Thummalapalli & Michael J. Betti & Lydia Yao & Zoe Quandt & Karmugi Balaratnam & Cosmin A. Bejan & Eduardo Cardenas & Christina J. Falcon & David M. Faleck & Matthew A. Gubens & S, 2024. "Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis," Nature Communications, Nature, vol. 15(1), pages 1-10, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-023-44512-4
    DOI: 10.1038/s41467-023-44512-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-44512-4
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-44512-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Clare Bycroft & Colin Freeman & Desislava Petkova & Gavin Band & Lloyd T. Elliott & Kevin Sharp & Allan Motyer & Damjan Vukcevic & Olivier Delaneau & Jared O’Connell & Adrian Cortes & Samantha Welsh &, 2018. "The UK Biobank resource with deep phenotyping and genomic data," Nature, Nature, vol. 562(7726), pages 203-209, October.
    2. Caroline Robert, 2020. "A decade of immune-checkpoint inhibitors in cancer therapy," Nature Communications, Nature, vol. 11(1), pages 1-3, December.
    3. Zia Khan & Christian Hammer & Jonathan Carroll & Flavia Nucci & Sergio Ley Acosta & Vidya Maiya & Tushar Bhangale & Julie Hunkapiller & Ira Mellman & Matthew L. Albert & Mark I. McCarthy & G. Scott Ch, 2021. "Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    4. Michael Conroy & Jarushka Naidoo, 2022. "Immune-related adverse events and the balancing act of immunotherapy," Nature Communications, Nature, vol. 13(1), pages 1-4, December.
    5. Seungho Cook & Wanson Choi & Hyunjoon Lim & Yang Luo & Kunhee Kim & Xiaoming Jia & Soumya Raychaudhuri & Buhm Han, 2021. "Accurate imputation of human leukocyte antigens with CookHLA," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Gunther Glehr & Paloma Riquelme & Katharina Kronenberg & Robert Lohmayer & Víctor J. López-Madrona & Michael Kapinsky & Hans J. Schlitt & Edward K. Geissler & Rainer Spang & Sebastian Haferkamp & Jame, 2024. "Restricting datasets to classifiable samples augments discovery of immune disease biomarkers," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    2. Matteo Di Scipio & Mohammad Khan & Shihong Mao & Michael Chong & Conor Judge & Nazia Pathan & Nicolas Perrot & Walter Nelson & Ricky Lali & Shuang Di & Robert Morton & Jeremy Petch & Guillaume Paré, 2023. "A versatile, fast and unbiased method for estimation of gene-by-environment interaction effects on biobank-scale datasets," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    3. Vincent Michaud & Eulalie Lasseaux & David J. Green & Dave T. Gerrard & Claudio Plaisant & Tomas Fitzgerald & Ewan Birney & Benoît Arveiler & Graeme C. Black & Panagiotis I. Sergouniotis, 2022. "The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    4. Natalie DeForest & Yuqi Wang & Zhiyi Zhu & Jacqueline S. Dron & Ryan Koesterer & Pradeep Natarajan & Jason Flannick & Tiffany Amariuta & Gina M. Peloso & Amit R. Majithia, 2024. "Genome-wide discovery and integrative genomic characterization of insulin resistance loci using serum triglycerides to HDL-cholesterol ratio as a proxy," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    5. Dick Schijven & Sourena Soheili-Nezhad & Simon E. Fisher & Clyde Francks, 2024. "Exome-wide analysis implicates rare protein-altering variants in human handedness," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    6. Sylvia Hartmann & Summaira Yasmeen & Benjamin M. Jacobs & Spiros Denaxas & Munir Pirmohamed & Eric R. Gamazon & Mark J. Caulfield & Harry Hemingway & Maik Pietzner & Claudia Langenberg, 2023. "ADRA2A and IRX1 are putative risk genes for Raynaud’s phenomenon," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    7. Mit Shah & Marco H. A. Inácio & Chang Lu & Pierre-Raphaël Schiratti & Sean L. Zheng & Adam Clement & Antonio Marvao & Wenjia Bai & Andrew P. King & James S. Ware & Martin R. Wilkins & Johanna Mielke &, 2023. "Environmental and genetic predictors of human cardiovascular ageing," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    8. Zhaotong Lin & Wei Pan, 2024. "A robust cis-Mendelian randomization method with application to drug target discovery," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    9. Zhening Liu & Hangkai Huang & Jiarong Xie & Yingying Xu & Chengfu Xu, 2024. "Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank," Nature Communications, Nature, vol. 15(1), pages 1-10, December.
    10. Junqing Xie & Shuo Feng & Xintong Li & Ester Gea-Mallorquí & Albert Prats-Uribe & Dani Prieto-Alhambra, 2022. "Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    11. Rongtao Jiang & Stephanie Noble & Matthew Rosenblatt & Wei Dai & Jean Ye & Shu Liu & Shile Qi & Vince D. Calhoun & Jing Sui & Dustin Scheinost, 2024. "The brain structure, inflammatory, and genetic mechanisms mediate the association between physical frailty and depression," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    12. Yue Wang & Shi-Kun Zhou & Yan Wang & Zi-Dong Lu & Yue Zhang & Cong-Fei Xu & Jun Wang, 2023. "Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    13. Romain Fournier & Zoi Tsangalidou & David Reich & Pier Francesco Palamara, 2023. "Haplotype-based inference of recent effective population size in modern and ancient DNA samples," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    14. Nicole Deflaux & Margaret Sunitha Selvaraj & Henry Robert Condon & Kelsey Mayo & Sara Haidermota & Melissa A. Basford & Chris Lunt & Anthony A. Philippakis & Dan M. Roden & Joshua C. Denny & Anjene Mu, 2023. "Demonstrating paths for unlocking the value of cloud genomics through cross cohort analysis," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
    15. George B. Busby & Scott Kulm & Alessandro Bolli & Jen Kintzle & Paolo Di Domenico & Giordano Bottà, 2023. "Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    16. van den Berg, Gerard J. & von Hinke, Stephanie & Wang, R. Adele H., 2022. "Prenatal Sugar Consumption and Late-Life Human Capital and Health: Analyses Based on Postwar Rationing and Polygenic Scores," IZA Discussion Papers 15544, Institute of Labor Economics (IZA).
    17. Xingjie Hao & Zhonghe Shao & Ning Zhang & Minghui Jiang & Xi Cao & Si Li & Yunlong Guan & Chaolong Wang, 2023. "Integrative genome-wide analyses identify novel loci associated with kidney stones and provide insights into its genetic architecture," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    18. Ruoyu Tian & Tian Ge & Hyeokmoon Kweon & Daniel B. Rocha & Max Lam & Jimmy Z. Liu & Kritika Singh & Daniel F. Levey & Joel Gelernter & Murray B. Stein & Ellen A. Tsai & Hailiang Huang & Christopher F., 2024. "Whole-exome sequencing in UK Biobank reveals rare genetic architecture for depression," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    19. Shiyu Zhang & Zheng Wang & Yijing Wang & Yixiao Zhu & Qiao Zhou & Xingxing Jian & Guihu Zhao & Jian Qiu & Kun Xia & Beisha Tang & Julian Mutz & Jinchen Li & Bin Li, 2024. "A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    20. Yunhe Wang & Binbin Su & Junqing Xie & Clemente Garcia-Rizo & Daniel Prieto-Alhambra, 2024. "Long-term risk of psychiatric disorder and psychotropic prescription after SARS-CoV-2 infection among UK general population," Nature Human Behaviour, Nature, vol. 8(6), pages 1076-1087, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-023-44512-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.